Mitchell Mcleod Pugh & Williams Inc. Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 8,653 shares of the healthcare conglomerate’s stock after purchasing an additional 23 shares during the quarter. UnitedHealth Group accounts for approximately 1.1% of Mitchell Mcleod Pugh & Williams Inc.’s investment portfolio, making the stock its 20th biggest holding. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $5,059,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. raised its position in UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after buying an additional 1,857 shares during the last quarter. Quent Capital LLC increased its holdings in UnitedHealth Group by 5.5% in the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after buying an additional 217 shares in the last quarter. Reynders McVeigh Capital Management LLC lifted its position in shares of UnitedHealth Group by 5.6% during the 1st quarter. Reynders McVeigh Capital Management LLC now owns 760 shares of the healthcare conglomerate’s stock valued at $376,000 after buying an additional 40 shares in the last quarter. Choate Investment Advisors lifted its stake in UnitedHealth Group by 15.6% in the 1st quarter. Choate Investment Advisors now owns 26,644 shares of the healthcare conglomerate’s stock valued at $13,181,000 after buying an additional 3,592 shares in the last quarter. Finally, NorthRock Partners LLC raised its holdings in shares of UnitedHealth Group by 21.0% during the first quarter. NorthRock Partners LLC now owns 8,114 shares of the healthcare conglomerate’s stock valued at $4,014,000 after acquiring an additional 1,408 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.7 %

Shares of UNH stock traded up $10.36 during trading hours on Friday, reaching $615.81. 3,875,838 shares of the stock were exchanged, compared to its average volume of 3,660,167. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $619.80. The firm has a market capitalization of $566.72 billion, a P/E ratio of 40.12, a P/E/G ratio of 1.81 and a beta of 0.58. The business’s fifty day moving average is $581.93 and its two-hundred day moving average is $545.03.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.56 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on UNH. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Wells Fargo & Company lifted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.